Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Angiotensin receptor II blockers

Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers decrease protein excretion and are the drugs of choice for hypertension in patients with CKD. [Pg.373]

Medications can increase the risk of hyperkalemia in patients with CKD, including angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers, used for the treatment of proteinuria and hypertension. Potassium-sparing diuretics, used for the treatment of edema and chronic heart failure, can also exacerbate the development of hyperkalemia, and should be used with caution in patients with stage 3 CKD or higher. [Pg.381]

ACE-I, angiotensin-converting enzyme inhibitor ADH, antidiuretic hormone (or vasopressin) ARB, angiotensin II receptor blocker, MESNA, sodium 2-mercaptoethanesulfonate TCA, tricyclic antidepressant Ul, urinary incontinence SUI, stress urinary incontinence UUI, urge urinary incontinence. [Pg.806]

Elevated blood pressure is common after ischemic stroke, and its treatment is associated with a decreased risk of stroke recurrence. The Joint National Committee and AHA/ASA guidelines recommend an angiotensin-converting enzyme inhibitor and a diuretic for reduction of blood pressure in patients with stroke or TIA after the acute period (first 7 days). Angiotensin II receptor blockers have also been shown to reduce the risk of stroke and should be considered in patients unable to tolerate angiotensinconverting enzyme inhibitors after acute ischemic stroke. [Pg.173]

For women with 140 to 179 mm Hg systolic or 90 to 109 mm Hg diastolic, the decision to continue or stop antihypertensive therapy during pregnancy is controversial. Antihypertensive drugs may be continued during pregnancy except for ACEIs and angiotensin II receptor blockers. [Pg.372]

Antihypertensive therapy should be initiated in diabetic or nondiabetic CKD patients with an angiotensin-converting enzyme inhibitor (ACEI) or an angiotensin II receptor blocker. Nondihydropyridine calcium channel blockers are generally used as second-line antiproteinuric drugs when ACEIs or angiotensin II receptor blockers are not tolerated. [Pg.873]

Angiotensin II receptor blockers Nonsteroidal antiinflammatory drugs... [Pg.984]

Drugs that affect all phosphodiesterase type 5 inhibitors include the following alcohol, amlodipine, angiotensin II receptor blockers, antacids, bendroflumethiazide, beta blockers, cimetidine, diuretics, enalaphl, metoprolol, nifedipine, rifampin, tacrolimus. [Pg.650]

Angiotensin II receptor blockers a-blockers a-, 8-blockers -blockers... [Pg.577]

If a patient is diabetic, ACE-I will be advised, because it may reduce new-onset of HE and protect against nephropathy. The use of an Angiotensin-II receptor blocker (ARB) is also a good choice for these diabetic patients and for their nephropathy. The basic concept of drug selection will be combination therapy using different classes such as ACE-I and... [Pg.594]

Rossing K, Jacobsen P, Pietraszek L, Parving HH. Reno-protective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy a randomized doubleblind crossover trial. Diabetes Care 2003 26 2268-74. [Pg.618]

Cozaar (hyzaar, losartan) Angiotensin II receptor blocker combination 0.7 0.6 0.6... [Pg.18]

Benicar HCT (olmesartan medoxomil) Angiotensin II receptor blocker a 0.1 0.4... [Pg.19]

AMS acute myocardial syndrome ANC absolute neutrophil count ANS autonomic nervous system APACHE Acute Physiologic and Chronic Health Evaluation ICU illness severity scoring system APAP acetaminophen [N-acetyl-p-aminophenol] aPTT activated partial thromboplastin time ARB angiotensin II receptor blocker ARDS adult respiratory distress syndrome... [Pg.454]

ACE inhibitors prevent the conversion of angiotensin I to angiotensin II. Angiotensin II receptor blockers block the effects of angiotensin II on the vasculature and various other tissues... [Pg.291]

Inhibition of the renin-angiotensin system (ACE inhibitors and angiotensin II receptor blockers]... [Pg.291]

ANTI HYPERTENSIVE VASODILATORS, ACE INHIBITORS, ANGIOTENSIN II RECEPTOR BLOCKERS, AND CALCIUM CHANNEL BLOCKERS ... [Pg.296]

Volpe M, Ruilope LM, Mclnnes GT, Waeber B, Weber MA. Angiotensin-II receptor blockers benefits beyond blood pressure reduction J Hum Hypertens. 2005 19 331-339. [Pg.305]

Angiotensin II receptor blockers Eprosartan (Teveten] Losartan (Cozaar] Valsartan (Diovan] Reduce angiotensin ll-induced peripheral vascular resistance and cardiovascular hypertrophy/remodeling by blocking angiotensin II receptors on the heart and vasculature... [Pg.335]

Consequendy, ARBs are used primarily as an alternative for people who are unable to tolerate traditional ACE inhibitors.17,46,47 Future studies comparing ACE inhibitors with these newer angiotensin II receptor blockers should help clarify which type of drug—or perhaps a combination of the two—provides optimal treatment in heart failure.17... [Pg.340]

Levine TB, Levine AB. Rationale for the use of angiotensin II receptor blockers in patients with left ventricular dysfunction (part I of II). Clin Cardiol. 2005 28 215-218. [Pg.345]


See other pages where Angiotensin receptor II blockers is mentioned: [Pg.395]    [Pg.1978]    [Pg.25]    [Pg.379]    [Pg.662]    [Pg.664]    [Pg.745]    [Pg.101]    [Pg.129]    [Pg.132]    [Pg.56]    [Pg.370]    [Pg.153]    [Pg.158]    [Pg.158]    [Pg.18]    [Pg.19]    [Pg.1396]    [Pg.1397]    [Pg.1399]    [Pg.296]    [Pg.297]    [Pg.339]    [Pg.340]    [Pg.340]    [Pg.340]   
See also in sourсe #XX -- [ Pg.13 ]

See also in sourсe #XX -- [ Pg.37 , Pg.381 ]

See also in sourсe #XX -- [ Pg.103 , Pg.104 , Pg.169 ]

See also in sourсe #XX -- [ Pg.752 , Pg.753 , Pg.754 , Pg.755 , Pg.756 ]

See also in sourсe #XX -- [ Pg.115 ]

See also in sourсe #XX -- [ Pg.136 ]




SEARCH



Angiotensin II

Angiotensin II receptor

Angiotensin II receptor blockers ARBs)

Angiotensin receptor blockers

Angiotensin receptors

Receptor blockers

© 2024 chempedia.info